These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2050424)

  • 1. Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia.
    Kern W; Kurrle E
    Infection; 1991; 19(2):73-80. PubMed ID: 2050424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1990 Jan; 88(1):36-42. PubMed ID: 2153006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
    Arning M; Wolf HH; Aul C; Heyll A; Scharf RE; Scheider W
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():137-42. PubMed ID: 2286588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
    Fox BC; Sollinger HW; Belzer FO; Maki DG
    Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin for prevention of bacterial infections in granulocytopenic patients.
    Kern W; Kurrle E; Vanek E
    Infection; 1987; 15(6):427-33. PubMed ID: 3481358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy.
    Liang RH; Yung RW; Chan TK; Chau PY; Lam WK; So SY; Todd D
    Antimicrob Agents Chemother; 1990 Feb; 34(2):215-8. PubMed ID: 2327768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
    Wade JC; de Jongh CA; Newman KA; Crowley J; Wiernik PH; Schimpff SC
    J Infect Dis; 1983 Apr; 147(4):624-34. PubMed ID: 6842003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
    Gurwith M; Truog K; Hinthorn D; Liu C
    Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
    McCarty JM; Richard G; Huck W; Tucker RM; Tosiello RL; Shan M; Heyd A; Echols RM
    Am J Med; 1999 Mar; 106(3):292-9. PubMed ID: 10190377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.
    Donnelly JP; Maschmeyer G; Daenen S
    Eur J Cancer; 1992; 28A(4-5):873-8. PubMed ID: 1524913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients.
    Bow EJ; Louie TJ; Riben PD; McNaughton RD; Harding GK; Ronald AR
    Am J Med; 1984 Feb; 76(2):223-33. PubMed ID: 6364804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies.
    Gualtieri RJ; Donowitz GR; Kaiser DL; Hess CE; Sande MA
    Am J Med; 1983 Jun; 74(6):934-40. PubMed ID: 6407305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy.
    Riben PD; Louie TJ; Lank BA; Kornachuk E; Gurwith MJ; Harding GK; Ronald AR
    Cancer; 1983 May; 51(9):1587-92. PubMed ID: 6339029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.
    Pizzo PA; Robichaud KJ; Edwards BK; Schumaker C; Kramer BS; Johnson A
    J Pediatr; 1983 Jan; 102(1):125-33. PubMed ID: 6336781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affairs Cooperative Study.
    Ward TT; Thomas RG; Fye CL; Arbeit R; Coltman CA; Craig W; Dana BW; Finegold SM; Lentino J; Penn RL
    Clin Infect Dis; 1993 Sep; 17(3):323-32. PubMed ID: 8218671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of Tarivid and Biseptol in the prevention of bacterial infections in patients with acute leukemia].
    Mociková K; Svác J; Faber E; Wildová B; Baníková I
    Vnitr Lek; 1992 Feb; 38(2):166-72. PubMed ID: 1595205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
    Dekker AW; Rozenberg-Arska M; Verhoef J
    Ann Intern Med; 1987 Jan; 106(1):7-11. PubMed ID: 3466563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
    Lew MA; Kehoe K; Ritz J; Antman KH; Nadler L; Kalish LA; Finberg R
    J Clin Oncol; 1995 Jan; 13(1):239-50. PubMed ID: 7799026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazol plus ofloxacin in prophylaxis of infections in patients with acute leukemia: a comparative study.
    Sajben P; Minárik T; Tomásik E; Mardiak J; Danisovicovà A; Trupl T; Krcméry V
    Support Care Cancer; 1993 Jul; 1(4):214-6. PubMed ID: 8193884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
    Winston DJ; Ho WG; Champlin RE; Karp J; Bartlett J; Finley RS; Joshi JH; Talbot G; Levitt L; Deresinski S
    Am J Med; 1987 Jun; 82(6B):40-6. PubMed ID: 3037899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.